                         SEQUENCE LISTING

<110>  THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
       SYRACUSE UNIVERSITY
       Hayes, Matthew Robert
       Doyle , Robert
       De Jonghe, Bart C.
       Borner, Tito
       Tinsley, Ian
 
<120>  PEPTIDE LIGANDS OF THE GDNF FAMILY RECEPTOR A-LIKE (GFRAL) 
       RECEPTOR

<130>  046483-7242WO1(02219)

<150>  US 62/801,391
<151>  2019-02-05

<160>  10    

<170>  PatentIn version 3.5

<210>  1
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide Sequence

<400>  1

Glu Asp Asp Val Ser Phe Gln Lys Leu Asp Asp Asn Val Arg Tyr His 
1               5                   10                  15      


Thr Leu Arg Lys 
            20  


<210>  2
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide Sequence

<400>  2

Asp Asp Asp Leu Ser Phe Gln Lys Leu Asp Asp Asn Val Tyr Tyr His 
1               5                   10                  15      


Leu Leu Arg Lys 
            20  


<210>  3
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide Sequence

<400>  3

Lys Leu Asp Asp Asn Val Tyr Tyr His Leu Leu Arg Lys 
1               5                   10              


<210>  4
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide Sequence

<400>  4

Lys Pro Met Val Leu Ile Gln Lys Thr Asp Thr Gly Val Ser Leu Gln 
1               5                   10                  15      


Thr Tyr Asp 
            


<210>  5
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide Sequence

<400>  5

Thr Lys Glu Glu Leu Ile His Ala His Ala Asp Pro Met Val Leu Ile 
1               5                   10                  15      


Gln Lys Thr Asp Thr Gly Val Ser Leu Gln Thr Tyr Asp 
            20                  25                  


<210>  6
<211>  31
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide Sequence

<400>  6

Val Leu Ser Pro Arg Glu Val Gln His Ala His Ala Asp Pro Met Val 
1               5                   10                  15      


Leu Ile Gln Lys Thr Asp Thr Gly Val Ser Leu Gln Thr Tyr Asp 
            20                  25                  30      


<210>  7
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide Sequence

<400>  7

Val Leu Ser Pro Arg Glu Val Gln His Ala His Ala Asp Pro Met Val 
1               5                   10                  15      


Leu Ile 
        


<210>  8
<211>  31
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide Sequence

<400>  8

Val Ile Thr Pro Arg Glu Val Gln His Ala His Ala Asp Pro Met Ile 
1               5                   10                  15      


Leu Ile Gln Lys Thr Asp Ser Gly Ile Ser Ile Gln Ser Tyr Glu 
            20                  25                  30      


<210>  9
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide Sequence

<400>  9

Val Ile Thr Pro Arg Glu Val Gln His Ala His Ala Asp Pro Met Ile 
1               5                   10                  15      


Leu Ile 
        


<210>  10
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide Sequence

<400>  10

Thr Lys Glu Glu Leu Ile His Ala His Ala Asp Pro Met Ile Leu Ile 
1               5                   10                  15      


Gln Lys Thr Asp Ser Gly Ile Ser Ile Gln Ser Tyr Glu 
            20                  25                  


